ArticleAmerican journal of therapeutics

Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry.

Jutta Bergler-Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.